Orthocell Ltd. is a bio-therapeutic technology development company. It focus on the development and commercialization of products for the regeneration and repair of soft tissue injuries such as tendons and ligaments as well as cartilage, using the patient's own stem cells. The company was founded by Paul Anderson and Min Hao Zheng on March 21, 2006 and is headquartered in Murdoch, Australia.
|Market Price at 23-11-2017||$0.39|
|Price to Earnings Ratio||-6.63|
|Market Capitalisation||$39.07 (million)|
|Return on Equity (ROE)||-77.46%|